These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 18446609)
1. Enhanced mucosal and systemic immune response with squalane oil-containing multiple emulsions upon intranasal and oral administration in mice. Shahiwala A; Amiji MM J Drug Target; 2008 May; 16(4):302-10. PubMed ID: 18446609 [TBL] [Abstract][Full Text] [Related]
2. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines. Patel GB; Zhou H; Ponce A; Chen W Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279 [TBL] [Abstract][Full Text] [Related]
3. Structural characterization of archaeal lipid mucosal vaccine adjuvant and delivery (AMVAD) formulations prepared by different protocols and their efficacy upon intranasal immunization of mice. Patel GB; Ponce A; Zhou H; Chen W J Liposome Res; 2008; 18(2):127-43. PubMed ID: 18569448 [TBL] [Abstract][Full Text] [Related]
4. Fabrication of chitosan-based emulsion as an adjuvant to enhance nasal mucosal immune responses. Li D; Li W; Li S; Zhang Y; Hu X; Liu S; Li Y Int J Biol Macromol; 2024 Jun; 272(Pt 2):132913. PubMed ID: 38851606 [TBL] [Abstract][Full Text] [Related]
5. Squalane-based emulsion vaccine delivery system: composition with murabutide activate Th1 response. Kantipakala R; Bonam SR; Vemireddy S; Miryala S; Halmuthur M SK Pharm Dev Technol; 2019 Mar; 24(3):269-275. PubMed ID: 29688119 [TBL] [Abstract][Full Text] [Related]
6. Per-oral immunization with antigen-conjugated nanoparticles followed by sub-cutaneous boosting immunization induces long-lasting mucosal and systemic antibody responses in mice. Howe SE; Konjufca VH PLoS One; 2015; 10(2):e0118067. PubMed ID: 25710518 [TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of Antigen Adjuvanted with AS04 and Its Deposition in the Upper Respiratory Tract after Intranasal Administration. Xu H; Alzhrani RF; Warnken ZN; Thakkar SG; Zeng M; Smyth HDC; Williams RO; Cui Z Mol Pharm; 2020 Sep; 17(9):3259-3269. PubMed ID: 32787271 [TBL] [Abstract][Full Text] [Related]
8. Surface assembly of poly(I:C) on polyethyleneimine-modified gelatin nanoparticles as immunostimulatory carriers for mucosal antigen delivery. Lin SF; Jiang PL; Tsai JS; Huang YY; Lin SY; Lin JH; Liu DZ J Biomed Mater Res B Appl Biomater; 2019 May; 107(4):1228-1237. PubMed ID: 30339742 [TBL] [Abstract][Full Text] [Related]
9. Ready-to-use colloidal adjuvant systems for intranasal immunization. Lee JJ; Shim A; Lee SY; Kwon BE; Kim SR; Ko HJ; Cho HJ J Colloid Interface Sci; 2016 Apr; 467():121-128. PubMed ID: 26775242 [TBL] [Abstract][Full Text] [Related]
10. Curdlan sulfate- Zhang S; Huang S; Lu L; Song X; Li P; Wang F Int J Nanomedicine; 2018; 13():2377-2394. PubMed ID: 29713168 [TBL] [Abstract][Full Text] [Related]
11. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza. Gupta NK; Tomar P; Sharma V; Dixit VK Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718 [TBL] [Abstract][Full Text] [Related]
12. Novel Th1-biased adjuvant, SPO1, enhances mucosal and systemic immunogenicity of vaccines administered intranasally in mice. Yu S; Tang C; Shi X; Yang P; Xing L; Wang X Vaccine; 2012 Aug; 30(36):5425-36. PubMed ID: 22709954 [TBL] [Abstract][Full Text] [Related]
13. Mucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune response. Pawar D; Jaganathan KS Drug Deliv; 2016; 23(1):185-94. PubMed ID: 24825494 [TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation of antigen/N-trimethylaminoethylmethacrylate chitosan conjugates for nasal immunization. Liu Q; Zhang C; Zheng X; Shao X; Zhang X; Zhang Q; Jiang X Vaccine; 2014 May; 32(22):2582-90. PubMed ID: 24681230 [TBL] [Abstract][Full Text] [Related]
15. Chitosan and trimethyl chitosan chloride (TMC) as adjuvants for inducing immune responses to ovalbumin in mice following nasal administration. Boonyo W; Junginger HE; Waranuch N; Polnok A; Pitaksuteepong T J Control Release; 2007 Aug; 121(3):168-75. PubMed ID: 17644205 [TBL] [Abstract][Full Text] [Related]
17. Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice. Alignani D; Maletto B; Liscovsky M; Rópolo A; Morón G; Pistoresi-Palencia MC J Leukoc Biol; 2005 Jun; 77(6):898-905. PubMed ID: 15758079 [TBL] [Abstract][Full Text] [Related]
18. Oral-antigen delivery via a water-in-oil emulsion system modulates the balance of the Th1/Th2 type response in oral tolerance. Masuda K; Horie K; Suzuki R; Yoshikawa T; Hirano K Pharm Res; 2003 Jan; 20(1):130-4. PubMed ID: 12608547 [TBL] [Abstract][Full Text] [Related]
19. Self-emulsifying drug delivery systems: In vivo evaluation of their potential for oral vaccination. Lupo N; Tkadlečková VN; Jelkmann M; Laffleur F; Hetényi G; Kubová K; Bernkop-Schnürch A Acta Biomater; 2019 Aug; 94():425-434. PubMed ID: 31228632 [TBL] [Abstract][Full Text] [Related]